BLSIF (Britannia Life Sciences) 3-Year FCF Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Britannia Life Sciences 3-Year FCF Growth Rate?

Britannia Life Sciences BLSIF 3-Year FCF Growth Rate is 0.00% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 1,108 Biotechnology companies, Britannia Life Sciences ranks worse than 90252.62% on this metric.

Britannia Life Sciences's Free Cash Flow per Share for the three months ended in Mar. 2026 was $-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Britannia Life Sciences  (OTCPK:BLSIF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Britannia Life Sciences 3-Year FCF Growth Rate Related Terms


BLSIF vs VRTX, REGN, MRNA: 3-Year FCF Growth Rate Comparison

For the Biotechnology subindustry, Britannia Life Sciences's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Britannia Life Sciences 3-Year FCF Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Britannia Life Sciences's 3-Year FCF Growth Rate falls into.



Britannia Life Sciences 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Frequently Asked Questions Learn more about 3-Year FCF Growth Rate →
What does a 3-Year FCF Growth Rate of 0.00% mean?
Britannia Life Sciences (BLSIF) has a 3-Year FCF Growth Rate of 0.00% as of Mar. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Britannia Life Sciences and its competitors. According to the industry distribution chart, Britannia Life Sciences ranks #999999 out of 1108 companies in the Biotechnology industry.
Is Britannia Life Sciences' 3-Year FCF Growth Rate too high?
Britannia Life Sciences' current 3-Year FCF Growth Rate is 0.00%. Based on the distribution chart, Britannia Life Sciences ranks #999999 out of 1108 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Britannia Life Sciences' 3-Year FCF Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Britannia Life Sciences ranks #999999 out of 1108 companies for 3-Year FCF Growth Rate. This places Britannia Life Sciences in the lower half of its industry. The industry median 3-Year FCF Growth Rate is 19.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Biotechnology company?
The median 3-Year FCF Growth Rate among Biotechnology companies is 19.25, based on 1,108 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Britannia Life Sciences and its competitors. For the Biotechnology industry, the median 3-Year FCF Growth Rate is 19.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Britannia Life Sciences's current 3-Year FCF Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (BLSIF) has a current 3-Year FCF Growth Rate of 0.00%. The current 3-Year FCF Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Britannia Life Sciences (BLSIF), the current 3-Year FCF Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Britannia Life Sciences Business Description

Other Exchanges BLAB:Canada
Address 120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.